Table 4. Treatment outcomes of patients having bacteriology confirmed pulmonary tuberculosis, clinically diagnosed pulmonary tuberculosis and extrapulmonary tuberculosis.

	PULMONARY TB		EXTRA PULMONARY TB
	Bacteriology confirmed	Clinically diagnosed	All	Pleural	Lymphatic	Abdominal	Osteo-Articular	CNS	Diss./ Mil	Other	NOS
TB cases(n)	18872	19430	15790	4668	3581	3313	1483	725	94	587	1339
Successfully Treated*	14959:79.3% (78.7–79.8)	16803:86.5% (86.0–87.0)	14125:89.5% (89.0–89.9)	4233:90.7% (89.8–91.5)	3217:89.8 (88.8–90.8)	3018:91.1%(90.1–92.0)	1288:86.9% (85.0–88.5)	539:74.3% (71.0–77.5)	78:83.0% (73.8–89.9)	496:84.5% (81.3–87.3)	1256:93.8% (92.4–95.0)
Lost to Follow up*	1147: 6.1% (5.7–6.4)	844:4.3% (4.1–4.6)	653:4.1% (3.8–4.5)	207:4.4% (3.9–5.1)	135:3.8% (3.2–4.4)	66:2.0% (01.5–2.5)	70;4.7% (3.7–5.9)	110;15.2% (12.6–18.0)	9:9.6% (4.4–17.4)	28:4.8% (3.2–6.8)	28:2.1% (1.4–3.0)
Treatment-Failure*	430;2.3% (2.1–2.5)	71;0.4% (0.3–0.5)	33;0.2% (0.1–0.3)	6;0.1% (0.05–0.3)	8;0.2% (0.09–0.4)	14;0.4% (0.2–0.7)	3;0.2% (0.04–0.6)	1;0.1% (00.0–0.7)	0;0.0% (0.0–0.03)	1;0.2% (0.0–0.9)	0;0.0% (0.0-.0.3)
Died*	616;3.3% (3.0–3.5)	410;2.1% (1.9–2.3)	207;1.3% (1.1–1.5)	67;1.4% (1.1–1.8)	33;0.9% (00.6–1.3)	40;1.2% (0.9–1.6)	15;1.0% (0.6–1.7)	32;4.4% (3.0–6.2)	4;4.3% (1.2–10.5)	3;0.5% (0.1–1.5)	13;1.0% (0.5–1.7)
Transferred out *	382;2.0% (1.8–2.2)	112;0.6% (0.5–0.7)	78;0.5% (0.4–0.6)	16;0.3% (0.2–0.6)	29;0.8% (0.5–1.2)	5;0.2% (0.05–0.4)	12;0.8% (0.4–1.4)	8;1.1% (0.5–2.2)	0;0.0% (0.0–0.03)	1;0.2% (0.0–0.9)	7;0.5% (0.2–1.1)
Not evaluated/ recorded*	1338;7.1% (6.7–7.5)	1190;6.1% (5.8–6.5)	694;4.4% (4.1–4.7)	139;3.0% (2.5–3.5)	159;4.4% (3.8–5.2)	170;5.1% (4.4–5.9)	95;6.4% (5.2–7.8)	35;4.8% (3.4–6.7)	3;3.2% (0.7–9.0)	58;9.9% (7.6–12.6)	35;2.6% (1.8–3.6)

*Data shown are number of patients;% (95%CI)

CNS-Central Nervous system, Diss/Mil-Disseminated/Miliary TB, NOS-Site not specified